The largest database of trusted experimental protocols

8 protocols using streptavidin horseradish peroxidase hrp

1

Quantifying TGF-β3 Release from Cartilage Scaffold

Check if the same lab product or an alternative is used in the 5 most similar protocols
The amount of TGF-β3 release from the growth factor loaded cartilage ECMderived scaffold was determined via ELISA, as previously described [7, 22] . 96 well plates were coated with capture antibody (360 µg ml -1 ) with mouse anti-human TGF-β3 (R&D Systems, UK). The samples (8 time points) and TGF-β3 standards (ProSpec-Tany TechnoGene Ltd, Israel) were incubated for 2 hours. After washing and drying, detection antibody (18 µg ml -1 of biotinylated goat anti-human TGF-β3) was added to the plate and incubated (2 hours). The next step was to wash, dry and incubate the plate in streptavidin-HRP (horseradish-peroxidase) (R&D Systems, UK) for 20 minutes in the dark. Substrate solution (1:1 mixture of H 2 O 2 and tetramethylbenzidine; R&D Systems, UK) was added to each well, followed by incubation (20 minutes) avoiding direct light. Stop solution (2 N H 2 SO 4 ; Sigma-Aldrich, Germany) was added and the optical density was determined immediately with a plate reader set to 450 nm.
+ Open protocol
+ Expand
2

TGF-β3 Quantification in ECM Scaffolds

Check if the same lab product or an alternative is used in the 5 most similar protocols
The TGF-β3 present in the ECM-derived scaffolds before seeding with FPSC was measured using a previously reported protocol 19 . Briefly, the scaffolds were treated with a solution of 4 M guanidine hydrochloride (Pierce) at 4°C for 2 days to extract any growth factors. TGF-β3 content was determined by ELISA 6c, [19] [20] . By following manufacturer instructions, capture antibody (360 µg ml -1 ) was in 96 well plates (mouse anti-human TGF-β3; R&D Systems, UK). The samples and standards (ProSpec-Tany TechnoGene Ltd, Israel) were incubated (2h). Furthermore, detection antibody (18 µg ml -1 of biotinylated goat antihuman TGF-β3) was added and incubated (2h). Next, the plate was washed, dried and incubated in streptavidin-HRP (horseradish-peroxidase; R&D Systems, UK). Substrate solution (1:1 mixture of H 2 O 2 and tetramethylbenzidine; R&D Systems, UK) was added to each well, followed by incubation (no light). Stop solution (2N H 2 SO 4 ; Sigma-Aldrich) was added and the optical density was determined (450 nm).
+ Open protocol
+ Expand
3

CXCL9 Peptides Compete with VEGF165 for HS Binding

Check if the same lab product or an alternative is used in the 5 most similar protocols
The ability of the CXCL9-derived peptides to compete with VEGF165 for HS binding was assessed in an ELISA-like GAG binding assay. First, the GAG binding plates (Galen Laboratory Supplies, North Haven, CT, USA) were coated with 25 µg/mL HS (Iduron, Alderley Edge, UK) in standard assay buffer (SAB) [100 mM NaCl, 50 mM sodium acetate, 0.2% (v/v) Tween® 20 in ultrapure water, pH 7.2] at room temperature overnight. The plates were washed with SAB and blocked with blocking buffer [SAB supplemented with 0.2% (w/v) gelatin] at 37 °C for 1 h to prevent nonspecific binding. Then, dilutions of VEGF165 and the peptides, CXCL9(74-103) or CXCL9(86-103), were added and allowed to interact at 37 °C for 2 h. Unbound material was removed through washing and biotinylated polyclonal goat anti-human VEGF165 antibody (PeproTech) in blocking buffer was added to interact with HS-bound VEGF165 at 37 °C for 1 h. Following additional washing steps, detection was performed with streptavidin-horseradish peroxidase (HRP) (R&D Systems) in blocking buffer at 37 °C for 30 min and conversion of 3,3’,5,5’-tetramethylbenzidine (TMB) to a colorimetric signal in the presence of 0.015% (v/v) H2O2. The reaction was stopped by the addition of H2SO4 and the absorbance was measured at 450 nm. All incubation steps were performed in the dark.
+ Open protocol
+ Expand
4

Quantification of Murine SDF-1α Levels

Check if the same lab product or an alternative is used in the 5 most similar protocols
SDF-1α ELISAs (R&D Systems) was performed with either BM interstitial fluid or in medium conditioned by BMSCs cell culture as described previously (Herberg et al., 2013 (link)). The anti-SDF-1 capture antibody (R&D Systems) in sodium bicarbonate buffer pH 9.4 was bound to MaxiSorp™ 96-well plates (Nunc, Thermo Fisher Scientific) overnight. Plates were blocked for 2 h with 1% BSA in PBS. Murine SDF-1α (PeproTech, Rocky Hill, NJ, USA) standards and samples (1:2 diluted) were incubated for 2 h prior to incubating with the biotinylated anti-SDF-1α (2 h; R&D Systems). Streptavidin-horseradish peroxidase (HRP) (R&D Systems) was incubated for 20 min followed by the substrate reagent (R&D Systems) for 20 min. Sulfuric acid (2 N) was added to stop the enzymatic color reaction and absorbance was read at 450 nm. SDF-1α protein expression was calculated using standard curves and normalized to total protein, which was quantified using the EZQ® Protein Quantitation Kit (Invitrogen).
+ Open protocol
+ Expand
5

In Vitro Permeability Assay Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
For the in vitro permeability assay, cells (2×105) were grown on a transwell insert (0.4 µm; Corning B.V. Life Sciences, The Netherlands) until a monolayer was formed. The upper chambers were reconstituted with 10% FBS-containing medium with MIF and inhibitors. At the indicated time points, the media in the upper chambers were replaced with 300 µl of serum-free media containing 4.5 µl of streptavidin-horseradish peroxidase (HRP) (R&D Systems, Inc., Minneapolis, MN). The media (20 µl) in the lower chambers were collected 5 min after adding streptavidin-HRP and assayed for HRP activity by adding 100 µl of 3,3′,5,5′-tetramethylbenzidine (TMB) substrate (R&D Systems). Color development was detected using a VersaMax microplate reader (Molecular Devices, Sunnyvale, CA) at 450 nm.
+ Open protocol
+ Expand
6

Assessing HUVEC Barrier Permeability

Check if the same lab product or an alternative is used in the 5 most similar protocols
HUVECs (1× 105) were grown on the upper chambers of Transwell plates (0.4 μm; Corning, The Netherlands) until a monolayer was formed. The HUVECs monolayer was coincubated with BSA or NS1-treated washed platelets (1×107, 200 μl) along with Tyrode’s buffer. After the indicated time point, the upper chambers were reconstituted with 300 μl serum-free media, which contained 3 μl of streptavidin-horseradish peroxidase (HRP) (R&D Systems). Fifty microliters of medium in the lower chamber was collected 10 min after adding streptavidin-HRP and was assayed for HRP activity by adding 100 μl of 3,3',5,5'-tetramethylbenzidine (TMB) substrate (R&D Systems). The color development was detected by a VersaMax microplate reader (Molecular Devices, Sunnyvale, CA) at 450 nm.
+ Open protocol
+ Expand
7

Transwell Permeability Assay for HUVEC Monolayer Integrity

Check if the same lab product or an alternative is used in the 5 most similar protocols
A Transwell permeability assay was performed as described in a previous study [58 ]. HUVECs (2 x 105) were grown on a Transwell insert (0.4 μm; Corning Life Sciences, Corning, NY, USA) until a monolayer formed. The upper chambers were reconstituted with 20 μg/ml NS1, culture supernatant from NS1-activated THP-1 cells, or the inhibitor-containing medium. After 24 h, the upper chambers were reconstituted with 300 μl of serum-free media containing 4.5 μl of streptavidin-horseradish peroxidase (HRP; R&D Systems, Inc., Minneapolis, MN, USA). Next, 20 μl of medium in the lower chamber was collected 5 min after the addition of streptavidin-HRP and was assayed for HRP activity by the addition of 100 μl of 3,3',5,5'-tetramethylbenzidine (TMB) substrate (R&D Systems). The color development at 450 nm was measured with a VersaMax microplate reader (Molecular Devices, Sunnyvale, CA, USA).
+ Open protocol
+ Expand
8

Quantitative ELISA Assay for α-Synuclein

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total α-syn level was determined by sandwich ELISA. Mouse
monoclonal anti-α-syn antibody (0.5 μg/ml; BD Biosciences, Oxford, UK)
was coated onto a NUNC Maxisorp 96-well plate overnight at RT. The plate
was washed in PBS/0.01% tween-20 and blocked for 1.5 hours in 1% BSA/PBS.
Tissue samples (insoluble and soluble extracts diluted 1:200 in PBS) were
added for two hours at RT with constant shaking. The plate was rinsed,
tapped dry and biotinylated polyclonal anti-α-synuclein (1 μg/ml; R&D
Systems, Oxford, UK) diluted in PBS was added for two hours at RT. The
plate was rinsed and tapped dry, streptavidin-horseradish peroxidase
(HRP) (1:200, R&D Systems) was added for 20 minutes and, after
further washing, chromogenic substrate (TMBS, R&D Systems) was added
for 20 minutes in the dark. The reaction was stopped with 2 N sulfuric
acid and absorbance at 450 nM read in a FLUOstar Optima plate reader (BMG
Labtech, Aylesbury, UK). Total α-syn levels were interpolated from
measurements made on serial dilutions of recombinant human α-syn ranging
from 62.5 to 0.98 ng/ml (rPeptide, Stratech, Suffolk, UK). Measurements
for each sample were repeated in duplicate.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!